Related Experiment Videos
Cytokines and therapeutic oligonucleotides
G Hartmann1, M Bidlingmaier, A Eigler
1Medizinische Klinik, Klinikum Innenstadt of the Ludwig-Maximilians-University, Munich, Germany.
Cytokines, Cellular & Molecular Therapy
|September 18, 1998
Summary
Therapeutic oligonucleotides, including antisense and aptamer types, offer promising ways to modulate immune functions. These synthetic nucleic acids are advancing into clinical trials for treating inflammatory diseases and for immunotherapy.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Therapeutic oligonucleotides are synthetic nucleic acids with diverse applications.
- Antisense oligonucleotides inhibit protein translation by targeting RNA.
- Aptamer oligonucleotides bind to specific proteins, with some exhibiting immunostimulatory effects.
Purpose of the Study:
- To review the application of therapeutic oligonucleotides in modulating immunological functions.
- To discuss technological aspects and therapeutic concepts.
- To summarize current clinical studies involving therapeutic oligonucleotides.
Main Methods:
- Review of existing literature on therapeutic oligonucleotides.
- Analysis of mechanisms of action for antisense and aptamer oligonucleotides.
- Examination of clinical trial data and preclinical development.
Main Results:
- Antisense oligonucleotides can specifically inhibit cytokine synthesis.
- Aptamer oligonucleotides can modulate immune responses through protein binding.
- Therapeutic oligonucleotides are progressing towards clinical applications.
Conclusions:
- Both antisense and aptamer oligonucleotides are valuable tools for immunomodulation.
- Clinical applications are emerging for inflammatory diseases and immunotherapy.
- Further research and development are ongoing for these promising nucleic acid therapies.